Compagnie Lebon operates within the Investors sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Compagnie Lebon with three other
financial institutions in Europe:
MedCap AB (publ)
sales of 709.00 million Swedish Kronor [US$73.10 million]
of which 56%
was Medical Technology),
NB Aurora SA SICAF RAIF
(60.25 million Euro [US$66.43 million]
Deutsche Beteiligungs AG
based in Germany
(66.37 million Euro [US$73.17 million]
of which 51%
was Private Equity Investments).
During the year ended December of 2018, sales at
Compagnie Lebon were 59.41 million Euro (US$65.50 million).
decrease of 23.2%
versus 2017, when the company's sales were 77.38 million Euro.
Contributing to the drop in overall sales was the 90.8% decline
in Financial Sector, from 762,000.00 Euro to 70,000.00 Euro.
There were also decreases in sales in
Property-Real Estate (down 73.6% to 4.02 million Euro)
However, these declines were partially offset by the increase in sales of
Hotel Sector (up 8.1% to 50.59 million Euro)
Holding and Other (up 50.1% to 3.84 million Euro)